Pharmaceuticals News and Research

RSS

New screening process helps better diagnose oral cancers

Patients with early stage oral cancer may benefit from a more advanced screening process allowing for a more accurate diagnosis, according to a study presented at the plenary session at the Multidisciplinary Head and Neck Cancer Symposium in Rancho Mirage, Calif., co-sponsored by the American Society for Therapeutic Radiology and Oncology, the American Society of Clinical Oncology and the American Head and Neck Society.

18 Jan 2007

Coating characterisation of polymer-coated cardiovascular stents

Coating characterisation of polymer-coated cardiovascular stents has been undertaken utilising ToFSIMS, DSIMS and 3DP.

16 Jan 2007

Surface analysis for transdermal patches

One of the fastest growing sectors in drug delivery is the use of transdermal patches.

16 Jan 2007

When the drugs don't work

Using state-if-the-art surface analysis techniques these two manufacturing routes can now be distinguished often enabling counterfeit drugs to be identified.

16 Jan 2007

Neuren reports successful NNZ-2566 safety trial results

Neuren Pharmaceuticals Ltd has successfully completed a Phase 1 safety and tolerability trial of its second lead candidate, NNZ-2566, which is being developed to treat traumatic brain injury (TBI).

16 Jan 2007

CogState issued US patent

CogState has announced that it has been issued a patent from the Unites States Patent & Trade Mark Office (US patent no. 7,163,513) for the key technology platform used in its computer-based tests of brain function.

16 Jan 2007

Pilot project for Bulgarian electronic health card assigned to ICW and Cisco

Three general practitioners, five pharmacies, and 1,000 patients will be included in the pilot project for a national electronic health card in Bulgaria.

16 Jan 2007

Nanoparticles yield delivery tools for therapeutic nucleic acids

Cancer researchers hold great hope that nucleic acid-based therapeutics, such as anticancer genes, antisense oligonucleotides, and small interfering RNA (siRNA) molecules, will prove to be powerful antitumor agents.

16 Jan 2007

Race to accelerate tuberculosis drug development

Each year, tuberculosis kills nearly two million people while an estimated nine million develop the disease -- with the hardest-hit areas in AIDS-afflicted developing nations.

14 Jan 2007

Major variations in Medicare drug costs

Soon, Congress may vote on whether to require the Medicare system to negotiate lower prices for medicines taken by millions of seniors enrolled in Medicare Part D prescription drug plans.

10 Jan 2007

India's decision to abide to pharma patents could limit access to medicines

India has become the "premier drug provider for the developing world" by producing generic versions of some of the world's most effective medicines, including antiretroviral drugs, but the country's decision to adhere to international patent regulations could limit access to generic drugs in the developing world, the Christian Science Monitor reports.

9 Jan 2007

Brain injury cognitive rehab not covered by many insurers

The Wall Street Journal on Monday examined how many brain injury patients who experience subsequent problems with memory, mental processing or behavior often do not receive cognitive rehabilitation because their health insurers do not cover the treatment.

9 Jan 2007

EDMA welcomes 7 new members

EDMA, the European Diagnostic Manufacturers Association, enlarges its membership with six new companies: BioSystems SA, Diagnostica Stago, Innogenetics, Luminex Corporation, Orion Diagnostica and Tecan, and the Foundation for Innovative New Diagnostics (FIND).

9 Jan 2007

MedImmune statement on MedImmune vs. Genentech Supreme Court decision

MedImmune issued the following statement regarding today's U.S. Supreme Court decision in MedImmune, Inc. vs. Genentech, Inc. et al.

9 Jan 2007

WHO tackles rabies, snake bites and scorpion stings

Although more than 12 million people each year are bitten by dogs or snakes, or stung by scorpions, the world's capacity to treat them is inadequate.

9 Jan 2007

Cell therapy for Parkinson's

Parkinson's disease is one of the commonest afflictions caused by damage to the nerve cells of the brain. Patients suffer from muscular tremors and rigidity, and their movements are severely impaired.

8 Jan 2007

Does industry sponsorship undermine nutrition research?

Researchers from the Children's Hospital, Boston, USA and the Center for Science in the Public Interest, Washington, D. C., USA, have found that there is a high potential for research findings into non-alcoholic drinks to be affected by bias from companies providing funding.

8 Jan 2007

New Medicare payment method for prescription drugs covered under Part B reducing spending

Medicare's new payment method for reimbursing physicians for prescription drugs under Part B has reduced spending, according to a report to Congress prepared by the Medicare Payment Advisory Commission, CQ HealthBeat reports.

7 Jan 2007

Democrats plan to introduce bills addressing stem cell research, Rx benefit

House Democrats plan to introduce bills that would reduce restrictions on federal funding for embryonic stem cell research and allow HHS to negotiate directly with pharmaceutical companies on prices for medications under the Medicare prescription drug benefit, incoming House Majority Leader Steny Hoyer (D-Md.) said on Wednesday, CQ Today reports.

7 Jan 2007

Vaccine purchase plan for diseases auch as HIV/AIDS, tuberculosis, malaria needs political will, funding pledges

The advance market commitment plan aimed at funding the development of vaccines for diseases -- including HIV/AIDS, tuberculosis and malaria -- that largely affect developing countries is "a new way for partners in the private and public sectors to solve an old problem".

7 Jan 2007